FDA 483 Database
FDA Form 483s Issued in February 2023
Every published Form FDA 483 issued in February 2023, drawn from the FDA OII FOIA Electronic Reading Room. Each row links to the FDA source record.
5
Published 483s in February 2023
5
Distinct firms
Form 483s issued in February 2023
BlendHouse LLCFDA
- FEI
- 3015728839
- Issued
- Feb 17, 2023
- Establishment
- Manufacturer
- Location
- Pennsylvania, United States
Jubilant HollisterStier General PartnershipFDA
- FEI
- 3001623073
- Issued
- Feb 28, 2023
- Establishment
- Finished Pharmaceutical Manufacturer
- Location
- Canada
AGC BiologicsFDA
- FEI
- 3000209996
- Issued
- Feb 10, 2023
- Establishment
- Human Drug Manufacturer
- Location
- United States
Nephron Sterile Compounding Center LLCFDA
- FEI
- 3011158388
- Issued
- Feb 10, 2023
- Establishment
- Outsourcing Facility
- Location
- South Carolina, United States
Cipla LimitedFDA
- FEI
- 3008581988
- Issued
- Feb 17, 2023
- Establishment
- Finished Pharmaceutical Manufacturer
- Location
- United States
| Company | FEI | Establishment type | Location | Issued | Source |
|---|---|---|---|---|---|
| BlendHouse LLC | 3015728839 | Manufacturer | Pennsylvania, United States | Feb 17, 2023 | FDA |
| Jubilant HollisterStier General Partnership | 3001623073 | Finished Pharmaceutical Manufacturer | Canada | Feb 28, 2023 | FDA |
| AGC Biologics | 3000209996 | Human Drug Manufacturer | United States | Feb 10, 2023 | FDA |
| Nephron Sterile Compounding Center LLC | 3011158388 | Outsourcing Facility | South Carolina, United States | Feb 10, 2023 | FDA |
| Cipla Limited | 3008581988 | Finished Pharmaceutical Manufacturer | United States | Feb 17, 2023 | FDA |